A Prospective Pilot Study (BIO|SELECT Pilot)

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

201 participants

Study Classification

OBSERVATIONAL

Study Start Date

2017-11-07

Study Completion Date

2019-10-07

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Enrolled patients implanted with Biotronik CRT-D and QP lead equipped with MultiPole pacing mode is grouped into which programmed into MultiPole pacing, or conventional bi-ventricular pacing mode. They are followed up by seven month post implantation, and predefined cardiac functional parameters are collected at each visit.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

One Day Implantation Program for Heart Failure Patients Implanted With CRT-P

NCT05142293

Heart Failure

ACTIVE_NOT_RECRUITING

Assessment of Ventricular Arrhythmia Risk After CRT-D Replacement for Patients With Primary Prevention Indication

NCT02323503

Cardiac Resynchronization Biventricular Pacemakers, Artificial Cardioverter-Defibrillators, Implantable +1 more

COMPLETED

Echocardiography Guided Cardiac Resynchronization Therapy (EchoCRT)

NCT00683696

Heart Failure Ventricular Dyssynchrony

TERMINATED PHASE2/PHASE3

Evaluation of the BIOTRONIK AutoAdapt Algorithm for Continuous Automatic Adaptive Cardiac Resynchronization

NCT04774523

Heart Failure Cardiac Arrhythmia Left Ventricular Dysfunction

COMPLETED NA

Assessment of Pacing Stimulus Conduction and Latency Measurements in CRT-D Patients

NCT03314675

Heart Failure

TERMINATED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Enrolled patients will undergo the baseline medical tests to assess the cardiac functions (e.g. echo, blood test, and 12-Lead ECG) prior to the implantation of Biotronik CRT-D and QP lead featured with MultiPole Pacing parameter. At implantation, LV-LV conduction delays are measured in predefined LV pacing and sensing configurations. One month after the successful implantation, the patients revisit the investigation site to be adjudicated for programming MultiPole pacing or continuing bi-ventricular pacing mode, based on their echo readings by then. Patients are subsequently followed up at four and seven month post implantation to acquire the LV-LV conduction delays and echo readings, etc. at the time.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Heart Failure

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

To be eligible for the study enrollment, candidate patients must meet all of the following criteria

* Indicated for a CRT-D implantation
* Has never received CRT
* Planned to be implanted with a quadripolar LV Lead, and CRT-D with MultiPole pacing feature, both manufactured by BIOTRONIK
* Geographically stable and willing to comply with the required follow-up schedule
* With written informed consent

Exclusion Criteria

Candidate patients will not be eligible if either of the following criteria is applicable

* Underwent a cardiac surgery within last 3 months, or scheduled for cardiac surgery other than CRT implantation
* Life expectancy is less than a year
* Can not be programmed to MultiPole pacing "ON"
* Does not agree to the concept of HomeMonitoring System
* With known pregnancy
* At age below 20 years
* Participated in another interventional clinical study

Minimum Eligible Age

20 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No